Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renu Agarwal

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Molecular Aspects of Medicine|November 28, 2023
Genetic rodent models of glaucoma in representing disease phenotype and insights into the pathogenesisRenu Agarwal, Igor Iezhitsa
Experimental Biology and Medicine (Maywood, N.J.)|November 1, 2016
Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?Renu Agarwal, Puneet Agarwal
Expert Opinion on Therapeutic Targets|December 9, 2023
Advances in targeting the extracellular matrix for glaucoma therapy: current updatesRenu Agarwal, Igor Iezhitsa
Expert Opinion on Therapeutic Targets|March 4, 2014
Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathwaysRenu Agarwal, Puneet Agarwal
Ophthalmic Research|October 16, 2009
Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to playRenu Agarwal, Puneet Agarwal
Neural Regeneration Research|November 24, 2020
New solutions for old challenges in glaucoma treatment: is taurine an option to consider?Igor Iezhitsa, Renu Agarwal
Expert Opinion on Therapeutic Targets|June 9, 2018
Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?Puneet Agarwal, Renu Agarwal
Indian Journal of Ophthalmology|July 25, 2012
Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alphaRenu Agarwal, Puneet Agarwal
Expert Opinion on Drug Discovery|January 12, 2017
Rodent models of glaucoma and their applicability for drug discoveryRenu Agarwal, Puneet Agarwal
Expert Opinion on Therapeutic Targets|August 17, 2021
Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptorsPuneet Agarwal, Renu Agarwal
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Molecular Aspects of Medicine|November 28, 2023
Genetic rodent models of glaucoma in representing disease phenotype and insights into the pathogenesisRenu Agarwal, Igor Iezhitsa
Experimental Biology and Medicine (Maywood, N.J.)|November 1, 2016
Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?Renu Agarwal, Puneet Agarwal
Expert Opinion on Therapeutic Targets|December 9, 2023
Advances in targeting the extracellular matrix for glaucoma therapy: current updatesRenu Agarwal, Igor Iezhitsa
Expert Opinion on Therapeutic Targets|March 4, 2014
Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathwaysRenu Agarwal, Puneet Agarwal
Ophthalmic Research|October 16, 2009
Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to playRenu Agarwal, Puneet Agarwal
Neural Regeneration Research|November 24, 2020
New solutions for old challenges in glaucoma treatment: is taurine an option to consider?Igor Iezhitsa, Renu Agarwal
Expert Opinion on Therapeutic Targets|June 9, 2018
Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?Puneet Agarwal, Renu Agarwal
Indian Journal of Ophthalmology|July 25, 2012
Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alphaRenu Agarwal, Puneet Agarwal
Expert Opinion on Drug Discovery|January 12, 2017
Rodent models of glaucoma and their applicability for drug discoveryRenu Agarwal, Puneet Agarwal
Expert Opinion on Therapeutic Targets|August 17, 2021
Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptorsPuneet Agarwal, Renu Agarwal
Pageof 10